FDA Clearance Tracker · P020045-S073
FREEZOR XTRA SURGICAL CARDIAC CRYOABLATION DEVICE
Last checked: Nov 20, 2026Latest source record: Aug 31, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Aug 31, 2016
Approved
Time to decision
216 days
Received Jan 28, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P020045-S073
- Device name
- FREEZOR XTRA SURGICAL CARDIAC CRYOABLATION DEVICE
- Applicant
- Medtronic Cryocath, LP
- Applicant location
- Mounds View, MN
- Received
- Jan 28, 2016
- Decided
- Aug 31, 2016
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P020045
Device type
- Device type
- Cardiac ablation percutaneous catheter (LPB)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for the Freezor Xtra Cardiac CryoAblation Catheter, CryoConsole system, and related accessories. The device is indicated for the cryoablation of the conducting tissues of the heart in the treatment of patients with atrioventricular nodal reentrant tachycardia (AVNRT). The Freezor Xtra catheter is also intended for minimally invasive cardiac surgery procedures, including surgical treatment of cardiac arrhythmias. The Freezor Xtra catheter freezes the target tissue and blocks the electrical conduction by creating an inflammatory response or cryonecrosis.
Source documents
Other decisions for Medtronic Cryocath, LP
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P100010-S110 · Decided Jun 18, 2021 · 231 days after receipt · Panel Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
K202620 · Decided Nov 13, 2020 · 64 days after receipt
Device type: Catheter, Steerable (DRA) · Cardiology
- Arctic Front Advance, Arctic Front Advance Pro and Freezor MAX Cardiac Cryoablation CathetersPMA supplement
P100010-S098 · Decided Jun 23, 2020 · 242 days after receipt · Panel Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.